We hypothesize that a condition similar to obesity-induced FGF21 resistance may be induced by persistent HCV infection, which, in turn, results in the functional decline of the FGF21 endocrine system to maintain metabolic homeostasis, leading to the metabolic abnormalities frequently observed in hepatitis C patients. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.